Enhanced searching using a thesaurus
Details for Australian Patent Application No. 2006274496 (hide)
International Classifications
Event Publications
20 March 2008 PCT application entered the National Phase
PCT publication WO2007/012120 Priority application(s): WO2007/012120
7 July 2011 Application Accepted
Published as AU-B-2006274496
2 February 2012 Standard Patent Sealed
27 September 2012 Application for Amendment
The nature of the amendment is: Amend the name of the inventor to read Redfern, Victoria Lesley . Address for service in Australia - Redfern International Enterprises Pty Ltd G.P.O. Box 2262 Canberra ACT 2617 2006291439 2-(aminomethyl)-5-chlorobenzylamide derivatives and their use as inhibitors of the clotting factor Xa The Medicines Company (Leipzig) GmbH The nature of the amendment is: Amend the name of the inventor to read Doennecke, Daniel; Stuerzebecher, Anne; Schweinitz, Andrea; Stuerzebecher, Jorg; S
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser